Teladoc Health Inc (TDOC)
11.24
-0.05
(-0.44%)
USD |
NYSE |
May 31, 16:00
11.26
+0.02
(+0.18%)
After-Hours: 20:00
Teladoc Health Cash from Financing (TTM): 9.252M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 9.252M |
December 31, 2023 | 10.85M |
September 30, 2023 | 17.01M |
June 30, 2023 | 12.58M |
March 31, 2023 | 7.034M |
December 31, 2022 | 6.497M |
September 30, 2022 | 8.741M |
June 30, 2022 | 8.891M |
March 31, 2022 | 21.59M |
December 31, 2021 | 40.95M |
September 30, 2021 | 104.76M |
June 30, 2021 | 104.40M |
March 31, 2021 | 866.26M |
December 31, 2020 | 859.14M |
September 30, 2020 | 798.74M |
June 30, 2020 | 807.47M |
March 31, 2020 | 39.44M |
December 31, 2019 | 35.09M |
September 30, 2019 | 32.50M |
Date | Value |
---|---|
June 30, 2019 | 364.70M |
March 31, 2019 | 644.12M |
December 31, 2018 | 645.61M |
September 30, 2018 | 596.70M |
June 30, 2018 | 380.75M |
March 31, 2018 | 364.20M |
December 31, 2017 | 475.43M |
September 30, 2017 | 516.70M |
June 30, 2017 | 406.64M |
March 31, 2017 | 143.87M |
December 31, 2016 | 20.68M |
September 30, 2016 | 20.41M |
June 30, 2016 | 165.10M |
March 31, 2016 | 164.22M |
December 31, 2015 | 164.01M |
September 30, 2015 | 164.21M |
June 30, 2015 | 57.31M |
March 31, 2015 | 69.80M |
December 31, 2014 | 70.16M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
6.497M
Minimum
Dec 2022
866.26M
Maximum
Mar 2021
207.79M
Average
33.80M
Median
Cash from Financing (TTM) Benchmarks
10x Genomics Inc | 18.72M |
American Shared Hospital Services | 4.996M |
Novo Integrated Sciences Inc | 4.668M |
Astrana Health Inc | 116.87M |
Cryo-Cell International Inc | -0.7611M |